Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (541-550 of 6,828) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|October 1, 2024
FDA approves first monoclonal antibody for COPDAsher Mullard
Nature Reviews. Drug Discovery|November 5, 2024
Lundbeck pays US$2.6 billion for Longboard and its lead epilepsy drugAsher Mullard
Nature Reviews. Drug Discovery|November 5, 2022
FDA releases tissue-agnostic cancer drug draft guidanceAsher Mullard
Nature Reviews. Drug Discovery|November 12, 2022
Climbing cancer's MYC mountainAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2024
How GLP-1 went from being a hard-to-handle hormone to a blockbuster successAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2024
Anti-tau antibody stumbles in phase II Alzheimer trialAsher Mullard
Nature Reviews. Drug Discovery|July 8, 2025
Dual-payload ADCs move into first oncology clinical trialsAsher Mullard
Nature Reviews. Drug Discovery|October 22, 2024
FDA approves first claudin-18.2-targeted antibody for gastric cancerAsher Mullard
Nature Reviews. Drug Discovery|September 7, 2021
Monoclonal antibodies show promise in phase I malaria trialAsher Mullard
Nature Reviews. Drug Discovery|September 7, 2021
Pfizer's COVID-19 vaccine secures first full FDA approvalAsher Mullard
Pageof 683

Showing results (541-550 of 6,828) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|October 1, 2024
FDA approves first monoclonal antibody for COPDAsher Mullard
Nature Reviews. Drug Discovery|November 5, 2024
Lundbeck pays US$2.6 billion for Longboard and its lead epilepsy drugAsher Mullard
Nature Reviews. Drug Discovery|November 5, 2022
FDA releases tissue-agnostic cancer drug draft guidanceAsher Mullard
Nature Reviews. Drug Discovery|November 12, 2022
Climbing cancer's MYC mountainAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2024
How GLP-1 went from being a hard-to-handle hormone to a blockbuster successAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2024
Anti-tau antibody stumbles in phase II Alzheimer trialAsher Mullard
Nature Reviews. Drug Discovery|July 8, 2025
Dual-payload ADCs move into first oncology clinical trialsAsher Mullard
Nature Reviews. Drug Discovery|October 22, 2024
FDA approves first claudin-18.2-targeted antibody for gastric cancerAsher Mullard
Nature Reviews. Drug Discovery|September 7, 2021
Monoclonal antibodies show promise in phase I malaria trialAsher Mullard
Nature Reviews. Drug Discovery|September 7, 2021
Pfizer's COVID-19 vaccine secures first full FDA approvalAsher Mullard
Pageof 683